• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Alzheimers & Dementia. Choroid plexus alterations in long COVID and their associations with Alzheimer's disease risks

sharon sanders

Editor-in-Chief & President
h/t @morgfair, @curiouschinwag

Choroid plexus alterations in long COVID and their associations with Alzheimer's disease risks​


Huize Pang, Jennifer Frontera, Li Jiang, Chenyang Li, Allal Boutajangout, Zhe Sun, Ludovic Debure, Mobeena Ghuman, Alok Vedvyas, Arjun V. Masurkar, Thomas Wisniewski, Yulin Ge … See fewer authors
First published: 30 January 2026

https://doi.org/10.1002/alz.71020Digital Object Identifier (DOI)



Abstract​

INTRODUCTION​

Choroid plexus (ChP) enlargement is a neuroimaging biomarker of neuroinflammation and neurodegeneration. However, evidence of ChP structural and perfusion alterations in long coronavirus disease (COVID) and their clinical relevance remains limited.

METHODS​

This study included 86 long COVID, 67 recovered COVID, and 26 COVID-negative healthy controls (HCs). ChP volume and cerebral blood flow (CBF) were quantified, and their associations with Alzheimer's disease (AD) symptoms and plasma biomarkers were examined.

RESULTS​

Both patient groups showed higher ChP volume and lower CBF than HC. Relative to recovered COVID, long COVID patients had a larger ChP volume, but no significant difference in CBF. ChP volume correlated positively with glial fibrillary acidic protein (r = 0.35) and phosphorylated tau217 (p-tau217; r = 0.54), while CBF correlated negatively with p-tau217 (r = –0.56). Both ChP volume and CBF were associated with cognitive decline measured with Mini-Mental State Examination and Clinical Dementia Rating.

DISCUSSION​

These findings suggest that ChP differences in long COVID are associated with AD-related cognitive decline and increased plasma biomarkers.

Highlights​

  • Long coronavirus disease (COVID) patients show choroid plexus (ChP) enlargement and reduced cerebral blood flow.
  • ChP alterations are associated with Alzheimer's disease (AD)-related symptoms and plasma biomarker changes.
  • ChP alterations on magnetic resonance imaging may serve as imaging markers for tracking neurological symptoms and AD-related pathology in post-COVID patients.
more..... https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.71020
 
Back
Top Bottom